Rituximab Dosing in Glomerular Diseases: A Scoping Review

PURPOSE OF REVIEW: Rituximab is increasingly prescribed for glomerular diseases. However, the recently published Kidney Disease Improving Global Outcomes (KDIGO) 2021 Clinical Practice Guideline for the Management of Glomerular Diseases lacks details on recommended dosing regimens for most individua...

Descripción completa

Detalles Bibliográficos
Autores principales: Alzayer, Husam, Sebastian, Kuruvilla K., O’Shaughnessy, Michelle M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Narrative Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583230/
https://www.ncbi.nlm.nih.gov/pubmed/36275037
http://dx.doi.org/10.1177/20543581221129959

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583230/
https://www.ncbi.nlm.nih.gov/pubmed/36275037
http://dx.doi.org/10.1177/20543581221129959

Ejemplares similares